Hong Kong Pharma is a small Hong Kong-based company that helps Mainland Chinese consumers access OTC pharmaceutical products sourced from overseas markets, including Hong Kong, Taiwan, Japan, and parts of Europe. The company operates at the intersection of cross-border e-commerce and pharmaceutical logistics, managing the regulatory, warehousing, customs, and fulfillment work required to move OTC products into Mainland China legally. Hong Kong Pharma operates two divisions. Supply Chain Services (~61% of revenue) provides end-to-end logistics and fulfillment for cross-border OTC pharmaceutical products on a fee-for-service basis, handling everything from HKDOH regulatory enlistment and import/export permitting to warehousing, customs clearance, and last-mile delivery. Procurement and Distribution (~39% of revenue) involves Hong Kong Pharma buying OTC products directly from overseas suppliers and reselling them to merchants or distributors at a markup. Customers include e-commerce platform logistics partners like CaiNiao, online merchants operating storefronts on platforms like Tmall, JD.com, and Pinduoduo, and pharmaceutical distributors. As of March 2025, Hong Kong Pharma served over 300 online merchants, with CaiNiao as the largest single customer at ~11.5% of revenue. Revenue scales with order volume, and the company's proprietary ERP system automates warehouse workflows to manage costs. Hong Kong Pharma's regulatory licenses — including wholesale dealer and Chinese medicine wholesaler licenses — are a prerequisite to operating in this space and represent a barrier to entry for new competitors.